Skip to main navigation
  • ABOUT US
    • Management
    • Board of Directors
  • CLINICAL PROGRAMS
    • Our Focus
    • IDO Pathway & Indoximod
    • Posters & Publications
  • COLLABORATION
    • Industry
    • Advocacy
  • CAREERS
    • Culture
    • Benefits
    • Jobs
  • INVESTORS & MEDIA
    • Investor Relations

      • Investor Relations
      • Press Releases
      • Events & Presentations
      • Posters & Publications
      • Corporate Governance
        • Management
        • Board of Directors
        • Contact the Board
      • Financial Information
        • SEC Filings
        • Quarterly Results
      • Analyst Coverage
      • Investor FAQs
Contact us

Investors & Media

Home > Investor Relations > 8-K

SEC Filing Details

Document Details

Form
8-K
Filing Date
Nov 12, 2019
Document Date
Nov 12, 2019
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
NewLink Genetics Corporation
Issuer
NEWLINK GENETICS CORP

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

    Shareholder Tools

    • Email Alerts Subscription
    • Download Library
    • Print
    • Share
  • Facebook
  • Google
  • LinkedIn
  • Twitter
  • RSS

About Us
Management
Board of Directors

Clinical Programs
Our Focus
IDO Pathway & Indoximod
Posters & Publications

Collaboration
Industry
Advocacy

Careers
Culture
Benefits
Jobs

Investors and Media

Investor Relations

  • Investor Relations
  • Press Releases
  • Events & Presentations
  • Posters & Publications
  • Corporate Governance
    • Management
    • Board of Directors
    • Contact the Board
  • Financial Information
    • SEC Filings
    • Quarterly Results
  • Analyst Coverage
  • Investor FAQs



©2019 NewLink Genetics Corporation. All rights reserved.    

Terms & Conditions   |   Privacy Policy   |  Contact Us